The Voice of MedTech in Asia
HomeThe MedTech IndustryMedTech Industry in APAC
It is predicted that over 60% of the world’s population will be living in Asia by 2030 with one in four people over the age of 60 or older.
Driven by higher healthcare costs, an aging demographic, a rise in chronic diseases and a growing population of ever discerning healthcare consumers, the healthcare market in Asia Pacific is on track to achieve unprecedented growth. By 2022, the value of the APAC MedTech industry is expected to climb at a CAGR of 8.8 % to 157 billion USD.
This has created an abundance of opportunities for the healthcare industry to tap into, with innovations and products that are specific to the diseases and chronic health issues that affect those living in Asia Pacific.
APACMed provides a unifying voice for the medical devices and in-vitro diagnostics industry in Asia Pacific. Founded in 2014, APACMed strives to promote innovation and impact policy that advances healthcare access for patients.
© 2020 Asia Pacific Medical Technology Association Ltd. All rights reserved. Read Our Terms Of Use